vs
Autonomix Medical, Inc.（AMIX）与Apyx Medical Corp（APYX）财务数据对比。点击上方公司名可切换其他公司
Apyx Medical Corp自由现金流更多（$-2.8M vs $-3.0M）
Autonomix Medical是一家专注于心脏电生理领域的医疗科技企业，主要开发用于心律失常诊断与治疗的微创医疗设备，服务北美、欧洲地区的医疗机构与患者，致力于提升心律相关心脏疾病的诊疗效率与效果。
Apyx Medical前身是博维医疗，是美国的医疗器械制造商，专注生产电外科产品与能源技术相关医疗设备，公司总部位于佛罗里达州克利尔沃特，在保加利亚设有生产工厂。
AMIX vs APYX — 直观对比
营收规模更大
APYX
是对方的Infinity倍
$0
自由现金流更多
APYX
多$171.0K
$-3.0M
损益表 — Q3 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $0 | $19.2M |
| 净利润 | $-3.3M | $-1.3M |
| 毛利率 | — | 62.6% |
| 营业利润率 | — | 0.1% |
| 净利率 | — | -6.8% |
| 营收同比 | — | 34.7% |
| 净利润同比 | -20.2% | 71.9% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMIXAPYX
| Q4 25 | $0 | $19.2M | ||
| Q3 25 | $0 | $12.9M | ||
| Q2 25 | $0 | $11.4M | ||
| Q1 25 | $0 | $9.4M | ||
| Q4 24 | $0 | $14.2M | ||
| Q3 24 | $0 | $11.5M | ||
| Q2 24 | $0 | $12.1M | ||
| Q1 24 | — | $10.2M |
净利润AMIXAPYX
| Q4 25 | $-3.3M | $-1.3M | ||
| Q3 25 | $-7.5M | $-2.0M | ||
| Q2 25 | $-3.3M | $-3.8M | ||
| Q1 25 | $-3.2M | $-4.2M | ||
| Q4 24 | $-2.7M | $-4.6M | ||
| Q3 24 | $-2.8M | $-4.7M | ||
| Q2 24 | $-2.7M | $-6.6M | ||
| Q1 24 | — | $-7.6M |
毛利率AMIXAPYX
| Q4 25 | — | 62.6% | ||
| Q3 25 | — | 64.4% | ||
| Q2 25 | — | 62.3% | ||
| Q1 25 | — | 60.1% | ||
| Q4 24 | — | 63.0% | ||
| Q3 24 | — | 60.5% | ||
| Q2 24 | — | 61.7% | ||
| Q1 24 | — | 58.1% |
营业利润率AMIXAPYX
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | -6.5% | ||
| Q2 25 | — | -22.6% | ||
| Q1 25 | — | -32.4% | ||
| Q4 24 | — | -21.4% | ||
| Q3 24 | — | -31.6% | ||
| Q2 24 | — | -45.7% | ||
| Q1 24 | — | -64.6% |
净利率AMIXAPYX
| Q4 25 | — | -6.8% | ||
| Q3 25 | — | -15.4% | ||
| Q2 25 | — | -33.2% | ||
| Q1 25 | — | -44.0% | ||
| Q4 24 | — | -32.5% | ||
| Q3 24 | — | -40.9% | ||
| Q2 24 | — | -54.0% | ||
| Q1 24 | — | -74.0% |
每股收益（稀释后）AMIXAPYX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-0.19 | ||
| Q1 24 | — | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.9M | $31.7M |
| 总债务越低越好 | — | $37.5M |
| 股东权益账面价值 | $8.6M | $14.5M |
| 总资产 | $10.2M | $66.8M |
| 负债/权益比越低杠杆越低 | — | 2.58× |
8季度趋势，按日历期对齐
现金及短期投资AMIXAPYX
| Q4 25 | $9.9M | $31.7M | ||
| Q3 25 | $7.5M | $25.1M | ||
| Q2 25 | $8.6M | $29.3M | ||
| Q1 25 | $9.1M | $31.0M | ||
| Q4 24 | $11.8M | $31.7M | ||
| Q3 24 | $5.2M | $28.0M | ||
| Q2 24 | $6.8M | $32.7M | ||
| Q1 24 | — | $37.3M |
总债务AMIXAPYX
| Q4 25 | — | $37.5M | ||
| Q3 25 | — | $37.5M | ||
| Q2 25 | — | $37.5M | ||
| Q1 25 | — | $37.5M | ||
| Q4 24 | — | $37.5M | ||
| Q3 24 | — | $37.5M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AMIXAPYX
| Q4 25 | $8.6M | $14.5M | ||
| Q3 25 | $6.4M | $5.8M | ||
| Q2 25 | $7.0M | $7.3M | ||
| Q1 25 | $8.1M | $10.5M | ||
| Q4 24 | $9.7M | $14.2M | ||
| Q3 24 | $3.0M | $11.0M | ||
| Q2 24 | $5.3M | $14.7M | ||
| Q1 24 | — | $20.3M |
总资产AMIXAPYX
| Q4 25 | $10.2M | $66.8M | ||
| Q3 25 | $7.9M | $57.4M | ||
| Q2 25 | $9.0M | $58.2M | ||
| Q1 25 | $9.8M | $60.2M | ||
| Q4 24 | $12.0M | $64.8M | ||
| Q3 24 | $5.4M | $60.7M | ||
| Q2 24 | $7.1M | $65.4M | ||
| Q1 24 | — | $70.7M |
负债/权益比AMIXAPYX
| Q4 25 | — | 2.58× | ||
| Q3 25 | — | 6.41× | ||
| Q2 25 | — | 5.17× | ||
| Q1 25 | — | 3.57× | ||
| Q4 24 | — | 2.64× | ||
| Q3 24 | — | 3.40× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.0M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $-3.0M | $-2.8M |
| 自由现金流率自由现金流/营收 | — | -14.6% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-9.1M |
8季度趋势，按日历期对齐
经营现金流AMIXAPYX
| Q4 25 | $-3.0M | $-2.5M | ||
| Q3 25 | $-3.8M | $-3.5M | ||
| Q2 25 | $-2.6M | $-1.2M | ||
| Q1 25 | $-2.6M | $-702.0K | ||
| Q4 24 | $-2.3M | $-2.9M | ||
| Q3 24 | $-1.6M | $-4.4M | ||
| Q2 24 | $-1.9M | $-4.3M | ||
| Q1 24 | — | $-6.3M |
自由现金流AMIXAPYX
| Q4 25 | $-3.0M | $-2.8M | ||
| Q3 25 | — | $-4.1M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-757.0K | ||
| Q4 24 | $-2.3M | $-3.2M | ||
| Q3 24 | — | $-4.6M | ||
| Q2 24 | $-1.9M | $-4.6M | ||
| Q1 24 | — | $-6.4M |
自由现金流率AMIXAPYX
| Q4 25 | — | -14.6% | ||
| Q3 25 | — | -31.5% | ||
| Q2 25 | — | -13.2% | ||
| Q1 25 | — | -8.0% | ||
| Q4 24 | — | -22.4% | ||
| Q3 24 | — | -40.0% | ||
| Q2 24 | — | -38.0% | ||
| Q1 24 | — | -62.2% |
资本支出强度AMIXAPYX
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 4.0% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | — | 0.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
